tiprankstipranks
Inozyme reports FY24 EPS ($1.62), consensus ($1.51)
PremiumThe FlyInozyme reports FY24 EPS ($1.62), consensus ($1.51)
23d ago
Inozyme price target lowered to $30 from $43 at Piper Sandler
Premium
The Fly
Inozyme price target lowered to $30 from $43 at Piper Sandler
3M ago
Inozyme price target lowered to $11 from $14 at Wells Fargo
Premium
The Fly
Inozyme price target lowered to $11 from $14 at Wells Fargo
3M ago
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
PremiumCompany AnnouncementsInozyme Pharma’s Q3 2024 Financial and Clinical Progress
5M ago
Inozyme reports Q3 EPS (39c), consensus (44c)
Premium
The Fly
Inozyme reports Q3 EPS (39c), consensus (44c)
5M ago
Is INZY a Buy, Before Earnings?
Premium
Pre-Earnings
Is INZY a Buy, Before Earnings?
5M ago
Inozyme presents new data at ASBMR 2024 annual meeting
PremiumThe FlyInozyme presents new data at ASBMR 2024 annual meeting
6M ago
Inozyme initiated with a Buy at Stifel
Premium
The Fly
Inozyme initiated with a Buy at Stifel
7M ago
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100